ICD-10 Coding for Hemoglobin Glycosylated(E10.9T, E11.9, E11.9B)
Explore the ICD-10 coding for hemoglobin glycosylated (HbA1c), including documentation requirements, common pitfalls, and billing considerations.
Complete code families applicable to Hemoglobin Glycosylated
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| E11.9 | Type 2 diabetes mellitus without complications | Use when a patient has type 2 diabetes without any documented complications. |
|
| R73.03 | Prediabetes | Use when HbA1c indicates prediabetes without a diabetes diagnosis. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutHemoglobin Glycosylated
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Hemoglobin Glycosylated.
Failing to document diabetes type
Impact
Clinical: Inaccurate treatment plans., Regulatory: Non-compliance with coding standards., Financial: Potential claim denials.
Mitigation
Always specify diabetes type in documentation.
Using R73.09 instead of R73.03 for prediabetes
Impact
Reimbursement: Incorrect coding may lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate patient records.
Mitigation
Ensure HbA1c results are documented to support prediabetes diagnosis.
HbA1c Testing Documentation
Impact
Inadequate documentation of HbA1c testing frequency and necessity.
Mitigation
Ensure all HbA1c tests are justified with clinical notes.